Speakers

Ahmaya Mustafa, PharmD, BCPS, BCPP
Clinical Pearls 1

Arthur Walters, MD
RLS Management and Psychiatric Comorbidity Considerations

Ashley Maister, PharmD, BCPP
Clinical Pearls 2

Audrey Abelleira, PharmD, BCPS, BCPP
Clinical Pearls 1

Austin De La Cruz, PharmD, BCPP
Approaches to Managing Psychogenic Non-Epileptic Seizures (PNES)

Chelsea Di Polito, PharmD, BCPP
The Good, the Bad, and the Unknown of Psychotropic Stewardship Implementation: A Focus on Antipsychotics

Christine Rarrick, PharmD, MBA, BCPS, BCPP
Clinical Pearls 2

Diana V. Punko, MD, MS
Palliative Psychiatry for Severe, Persistent Mental Illness

Ericka Crouse, PharmD, BCPP, BCGP
Clinical Pearls 2

Greg A. Fonzo, Ph.D.
Psychedelics: Ethics and Real World Applications

Howard Pinderhughes, PhD
Gun Violence: Impact on Mental Health

Ilan Melnick, MD
Industry Showcase UZEDY: An LAI With a Spectrum of Key Attributes for the Treatment of Schizophrenia Supported by Teva Pharmaceutical

Julie Cerel, PhD
Living Through Loss - Navigating Loss by Suicide as a Clinician-Survivor

Kari Franson, PharmD, PhD, BCPP
Industry Symposium With ACPE Credit A New Script: Implementing Prescription Digital Therapeutics into Practice Supported by Boehringer Ingelheim

Katharine "Kaz" Joyer Nelson, MD, DFAPA
Evidence-based Management of Borderline Personality Disorder

Kristen Ward, PharmD, BCPP
Using Pharmacogenomics to Optimize Mental Health Comprehensive Medication Management

Megan J. Ehret, PharmD, MS, BCPP
Management of Clozapine-Resistant Schizophrenia

Megan Maroney, PharmD, BCPP
Insomnia: Treatment Resistance and Special Populations

Nena Bowman, PharmD, DABAT
Comprehensive Management of Psychiatric Medication Overdose

Noll L. Campbell, PharmD, MS
Anticholinergic Deprescribing: What We Don’t Know

Russell E. Spieth, MEd, PhD
Addressing Ambivalence and Non-Adherence to Mental Health Treatment

Shari N. Allen, PharmD, BCPP
Social Determinants of Health in the Treatment of Depression
Clinical Pearls 1

Stephen R. Saklad, PharmD, BCPP
Psychiatric and Neurologic Medication Pipeline

Steven W. Shoyer, PharmD, BCPP
Identification and Management of Illicit Substance Use (xylazine, fentanyl, kratom)

Tiffany R Buckley, PharmD, BCPS, BCPP
Role of Cannabis and Cannabidiol in the Treatment of Anxiety Disorders

Veronica Vernon, PharmD, BCPS, BCACP, MSCP
Integrating Contraceptive Care in Psychiatry: Best Practices

Vikram Patel, MBBS, PhD
Transforming Mental Health Systems: Lessons from the Global South